Effect of Neoadjuvant Therapies on Soft Tissue Sarcomas with Tail-like Lesions: A Multicenter Retrospective Study

被引:5
作者
Aiba, Hisaki [1 ]
Ikuta, Kunihiro [2 ]
Asanuma, Kunihiro [3 ]
Kawanami, Katsuhisa [4 ]
Tsukushi, Satoshi [5 ]
Matsumine, Akihiko [6 ]
Ishimura, Daisuke [7 ]
Nagano, Akihito [8 ]
Shido, Yoji [9 ]
Kozawa, Eiji [10 ]
Yamada, Kenji [11 ]
Wasa, Junji [12 ]
Kimura, Hiroaki [1 ]
Sakai, Takao [1 ]
Murakami, Hideki [1 ]
Sakai, Tomohisa [2 ]
Nakamura, Tomoki [3 ]
Nishida, Yoshihiro [2 ,13 ]
机构
[1] Nagoya City Univ, Grad Sch Med Sci, Dept Orthoped Surg, Nagoya, Aichi 4678601, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Orthopaed Surg, Nagoya, Aichi 4668560, Japan
[3] Mie Univ, Grad Sch Med, Dept Orthopaed Surg, Tsu, Mie 5148570, Japan
[4] Aichi Med Univ, Sch Med, Dept Orthopaed Surg, Nagakute, Aichi 4801195, Japan
[5] Aichi Canc Ctr Hosp, Div Orthopaed Surg, Nagoya, Aichi 4648681, Japan
[6] Univ Fukui, Fac Med Sci, Dept Orthopaed & Rehabil Med, Fukui 9101193, Japan
[7] Fujita Med Univ, Dept Orthopaed Surg, Toyoake, Aichi 4701192, Japan
[8] Gifu Univ, Grad Sch Med, Dept Orthopaed Surg, Gifu 5011194, Japan
[9] Hamamatsu Med Univ, Dept Orthopaed Surg, Hamamatsu, Shizuoka 4313125, Japan
[10] Nagoya Mem Hosp, Dept Orthopaed Surg, Nagoya, Aichi 4688250, Japan
[11] Okazaki City Hosp, Dept Orthoped Oncol, Okazaki, Aichi 4448553, Japan
[12] Shizuoka Canc Ctr Hosp, Div Orthopaed Oncol, Nagaizumi, Shizuoka 4110934, Japan
[13] Nagoya Univ Hosp, Dept Rehabil, Nagoya, Aichi 4668560, Japan
基金
日本学术振兴会;
关键词
soft tissue sarcoma; invasive front; tail-like lesion; myxofibrosarcoma; undifferentiated pleomorphic sarcoma; neoadjuvant therapy; radiotherapy; chemotherapy; LOW-GRADE MYXOFIBROSARCOMA; CLINICOPATHOLOGICAL ANALYSIS; ADJUVANT CHEMOTHERAPY; INFILTRATIVE GROWTH; SINGLE-INSTITUTION; IFOSFAMIDE; EXTREMITY; JAPAN; MRI; RADIOTHERAPY;
D O I
10.3390/cancers13153901
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary It is essential to focus on the tumor invasive front (tail-like lesion)-the soft tissue sarcoma's specific peripheral infiltrative growth characteristics-to avoid leaving unexpected tumor residues during surgery. This study aimed to analyze the effect of neoadjuvant therapy for highly malignant soft tissue tumors with tail-like lesions. From 2012 to 2019, 36 patients were treated with neoadjuvant therapy, including chemotherapy, radiotherapy, or both. Consequently, we observed shrinkage, and occasionally the disappearance of the tail-like lesion. The lesion's regression was related to the necrosis rate of the main part of the tumor. However, the regression of lesions was not directly related to the achievement of surgery with a microscopically negative margin or improvements of oncological outcomes. Thus, a more multi-angle evaluation to elaborate surgical strategy is necessary. Several types of soft tissue sarcomas have peripheral infiltrative growth characteristics called tail-like lesions. The efficacy of neoadjuvant therapy for tumors with tail-like lesions has not been elucidated. From 2012 to 2019, we analyzed 36 patients with soft tissue sarcoma with tail-like lesions treated with neoadjuvant therapy, including chemotherapy, radiotherapy, or both. The effect of neoadjuvant therapy on the tail sign was investigated by analyzing the change in tail-like lesions during neoadjuvant therapy and histological responses. The median length of the tail-like lesion reduced from 29.5 mm at initiation to 19.5 mm after neoadjuvant therapy. The extent of shrinkage in tail-like lesions was related to the histopathological responses in the main part of the tumor. Complete disappearance of the tail-like lesion was observed in 12 patients; however, it was not related to achieving a microscopically negative margin. The oncologic outcomes did not significantly differ between cases with and without the complete disappearance of tail-like lesions. This study indicated that the shrinkage of tail-like lesions did not have a significant effect on complete resection or improvements of clinical outcomes. A more comprehensive evaluation is needed to elaborate on the surgical strategy.
引用
收藏
页数:13
相关论文
共 41 条
[1]   Treatment of a Malignant Soft Tissue Tumor Arising in the Vicinity of the Sciatic Nerve with an In-Situ Preparation Technique and Intensive Multidisciplinary Therapy [J].
Aiba, Hisaki ;
Hayashi, Katsuhiro ;
Yamada, Satoshi ;
Okamoto, Hideki ;
Kimura, Hiroaki ;
Miwa, Shinji ;
Inatani, Hiroyuki ;
Otsuka, Takanobu ;
Murakami, Hideki .
CANCERS, 2019, 11 (04)
[2]   Clinical outcomes of radio-hyperthermo-chemotherapy for soft tissue sarcoma compared to a soft tissue sarcoma registry in Japan: a retrospective matched-pair cohort study [J].
Aiba, Hisaki ;
Yamada, Satoshi ;
Mizutani, Jun ;
Yamamoto, Norio ;
Okamoto, Hideki ;
Hayashi, Katsuhiro ;
Kimura, Hiroaki ;
Takeuchi, Akihiko ;
Miwa, Shinji ;
Kawai, Akira ;
Yoshimura, Kenichi ;
Tsuchiya, Hiroyuki ;
Otsuka, Takanobu .
CANCER MEDICINE, 2018, 7 (04) :1560-1571
[3]  
Akira K., 2020, JAP ORTH ASS CLIN PR JAP ORTH ASS CLIN PR, V3
[4]   Radiographic and Histologic Response to Neoadjuvant Radiotherapy in Patients With Soft Tissue Sarcoma [J].
Canter, Robert J. ;
Martinez, Steve R. ;
Tamurian, Robert M. ;
Wilton, Maaya ;
Li, Chin-Shang ;
Ryu, Janice ;
Mak, Walter ;
Monsky, Wayne L. ;
Borys, Dariusz .
ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (10) :2578-2584
[5]   Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma [J].
Davis, AM ;
O'Sullivan, B ;
Turcotte, R ;
Bell, R ;
Catton, C ;
Chabot, P ;
Wunder, J ;
Hammond, A ;
Benk, V ;
Kandel, R ;
Goddard, K ;
Zee, B ;
Day, A ;
Tu, DS ;
Pater, J .
RADIOTHERAPY AND ONCOLOGY, 2005, 75 (01) :48-53
[6]   New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) [J].
Eisenhauer, E. A. ;
Therasse, P. ;
Bogaerts, J. ;
Schwartz, L. H. ;
Sargent, D. ;
Ford, R. ;
Dancey, J. ;
Arbuck, S. ;
Gwyther, S. ;
Mooney, M. ;
Rubinstein, L. ;
Shankar, L. ;
Dodd, L. ;
Kaplan, R. ;
Lacombe, D. ;
Verweij, J. .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (02) :228-247
[7]  
ENNEKING WF, 1981, CANCER-AM CANCER SOC, V47, P1005, DOI 10.1002/1097-0142(19810301)47:5<1005::AID-CNCR2820470532>3.0.CO
[8]  
2-9
[9]  
Fanburg-Smith J C, 1999, Ann Diagn Pathol, V3, P1, DOI 10.1016/S1092-9134(99)80003-3
[10]  
Fernebro Josefin, 2006, Sarcoma, V2006, P1, DOI 10.1155/SRCM/2006/21251